DK0684816T3 - 5-HT2-receptorantagonister til behandling af venöse tilstande - Google Patents

5-HT2-receptorantagonister til behandling af venöse tilstande

Info

Publication number
DK0684816T3
DK0684816T3 DK93906979T DK93906979T DK0684816T3 DK 0684816 T3 DK0684816 T3 DK 0684816T3 DK 93906979 T DK93906979 T DK 93906979T DK 93906979 T DK93906979 T DK 93906979T DK 0684816 T3 DK0684816 T3 DK 0684816T3
Authority
DK
Denmark
Prior art keywords
treatment
receptor antagonists
venous conditions
venous
conditions
Prior art date
Application number
DK93906979T
Other languages
English (en)
Inventor
M Samir Amer
Original Assignee
Sam Amer & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sam Amer & Co Inc filed Critical Sam Amer & Co Inc
Application granted granted Critical
Publication of DK0684816T3 publication Critical patent/DK0684816T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93906979T 1992-01-09 1993-02-19 5-HT2-receptorantagonister til behandling af venöse tilstande DK0684816T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/818,389 US5266571A (en) 1992-01-09 1992-01-09 Treatment of hemorrhoids with 5-HT2 antagonists
PCT/US1993/001485 WO1994018958A1 (en) 1992-01-09 1993-02-19 5-ht2 receptor antagonist compositions useful in treating venous conditions

Publications (1)

Publication Number Publication Date
DK0684816T3 true DK0684816T3 (da) 2004-06-14

Family

ID=25225434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93906979T DK0684816T3 (da) 1992-01-09 1993-02-19 5-HT2-receptorantagonister til behandling af venöse tilstande

Country Status (11)

Country Link
US (2) US5266571A (da)
EP (1) EP0684816B1 (da)
KR (1) KR100278522B1 (da)
AT (1) ATE258789T1 (da)
AU (1) AU678149B2 (da)
CA (1) CA2156481C (da)
DE (1) DE69333413T2 (da)
DK (1) DK0684816T3 (da)
ES (1) ES2215990T3 (da)
PT (1) PT684816E (da)
WO (1) WO1994018958A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5780487A (en) * 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
US5869059A (en) * 1996-01-16 1999-02-09 Mon's Tea Partnership Herbal composition for hemorrhoid treatment
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
DE10025644A1 (de) * 2000-05-24 2001-12-06 Lohmann Therapie Syst Lts Schmales bandförmiges transdermales therapeutisches System zur Applikation von Wirkstoffen direkt über dem arteriellen oder venösen Gefäßsystem
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
WO2006026412A2 (en) * 2004-08-31 2006-03-09 Vnus Medical Technologies, Inc. Apparatus and material composition for permanent occlusion of a hollow anatomical structure
TW200635566A (en) * 2005-01-25 2006-10-16 Vnus Med Tech Inc Structures for permanent occlusion of a hollow anatomical structure
US20070082076A1 (en) * 2005-10-12 2007-04-12 Spencer Feldman Glutathione and coffee suppository
US9017361B2 (en) * 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
WO2012026914A1 (en) * 2010-08-23 2012-03-01 Sam Amer & Co., Inc. Methods and compositions for treating internal and external hemorrhoids
CN108440520A (zh) * 2018-03-12 2018-08-24 首都医科大学 苯并异噻唑类化合物及其制备方法和在治疗抑郁症方面的用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
USRE30812E (en) * 1971-03-03 1981-12-01 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
USRE30811E (en) * 1971-03-03 1981-12-01 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
ES456574A1 (es) * 1977-03-07 1978-02-16 Rocador Sa Procedimiento de obtencion de pentametil-carbamato de quer- cetina.
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4265887A (en) * 1979-12-11 1981-05-05 Breskman Joseph S Composition and method for treatment of hemorrhoids
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4539318A (en) * 1984-06-04 1985-09-03 Merck & Co., Inc. Tertiary aminohydroxypropoxy substituted thiadiazoles, pharmaceutical compositions and use
CA1246074A (en) * 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
US4665075A (en) * 1984-12-05 1987-05-12 Janssen Pharmaceutica N.V. Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4626433A (en) * 1985-05-20 1986-12-02 Preparation Gold, Inc. Remedy for hemorrhoids
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US5196405A (en) * 1987-07-08 1993-03-23 Norman H. Oskman Compositions and methods of treating hemorrhoids and wounds
IT8947616A0 (it) * 1989-02-06 1989-02-06 Verde Giancarlo Umberto Preparato per il trattamento e la cura delle emorroidi
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
CA2107669C (en) * 1992-02-07 2004-06-01 Makoto Okumura Preparation for treating wounds and hemorrhoides

Also Published As

Publication number Publication date
KR960700696A (ko) 1996-02-24
WO1994018958A1 (en) 1994-09-01
US5605902A (en) 1997-02-25
AU3774893A (en) 1994-09-14
AU678149B2 (en) 1997-05-22
ATE258789T1 (de) 2004-02-15
DE69333413D1 (de) 2004-03-11
EP0684816A1 (en) 1995-12-06
ES2215990T3 (es) 2004-10-16
CA2156481C (en) 2004-05-11
DE69333413T2 (de) 2004-12-02
US5266571A (en) 1993-11-30
EP0684816B1 (en) 2004-02-04
PT684816E (pt) 2004-06-30
CA2156481A1 (en) 1994-09-01
KR100278522B1 (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
DK0684816T3 (da) 5-HT2-receptorantagonister til behandling af venöse tilstande
ATE41419T1 (de) Bismaleimide und daraus erhaltene prepregharze.
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DK176487D0 (da) Middel til behandling af inflammationer i oejet
NO964236D0 (no) Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi
DK1305286T3 (da) Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
DK0767798T3 (da) Sterolderivater anvendt til regulering af meiose
DE69014684D1 (de) Biologisch abbaubare Polyphosphoester.
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
NO962187D0 (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
BR9811099A (pt) Inibidores de urocinase
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
DK0625987T3 (da) Aminoacetylmercaptoacetylamid-derivater, der kan anvendes som inhibitorer af enkephalinase og ACE
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
DK0759687T3 (da) Anvendelse af gelpræparater som bejdsemidler
IT1247796B (it) Derivati arilvinilamidici e procedimento per la loro preparazione
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
FI893163A0 (fi) Menetelmä 19-hydroksylaasi-inhibiittoreina käyttökelpoisten 19-substituoitujen progesteronijohdannaisten valmistamiseksi
DK4287D0 (da) Polyfluoralkylthiomethyl-forbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanneforbindelser som overfladeaktive midler
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
NO904858D0 (no) Fremgangsmaate til rask mottagersynkronisering under utnyttelse av enfeilkorrigerende koding.
DK68784D0 (da) Kontinuert fremgangsmade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler